M. Miller

Oncology · Clinical Cancer Research · 2004–2009

A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom M. Miller trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. D. de Bono
  2. I. J. Fidler
  3. P. Paterlini-Bréchot

Who trusts M. Miller overall

  1. G. Doyle
  2. L. Terstappen

Papers from M. Miller's perspective

Ordered by how strongly the researchers M. Miller trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. (Journal of Clinical Oncology)
  2. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited (Nature Reviews. Cancer)
  3. Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. (Journal of Clinical Oncology)
  4. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. (Cancer Research)
  5. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System (Clinical Cancer Research)
  6. Circulating tumor cells (CTC) detection: clinical impact and future directions. (Cancer Letters)
  7. Isolation of rare circulating tumour cells in cancer patients by microchip technology (Nature)
  8. Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival (Clinical Cancer Research)
  9. Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer (Clinical Cancer Research)
  10. Circulating Tumor Cell Number as a Prognostic Marker in Progressive Castration-Resistant Prostate Cancer: Use in Clinical Practice and Clinical Trials (The Lancet Oncology)

Their papers